Literature DB >> 26266895

Melanoma survival: sex does matter, but we do not know how.

Emanuele Crocetti1, Laura Fancelli, Gianfranco Manneschi, Adele Caldarella, Nicola Pimpinelli, Alessandra Chiarugi, Paolo Nardini, Carlotta Buzzoni.   

Abstract

The objective of this study was to provide further insights into the prognostic role of female sex in skin melanoma. The prognostic effect of sex in a population-based case series of 3900 skin melanomas in central Italy has been evaluated considering the possible confounding role of many demographic and clinical variables (age, period of diagnosis, Breslow's thickness, Clark level, ulceration, lymph node status, metastasis, histological type, skin site, and pathological T and N). Multiple imputations, according to chained equations, have been used for imputing incomplete values. A Cox proportional hazards model on the risk of death caused by melanoma was fitted. Univariate and multivariate effects of sex and of other variables were computed. The 5-year cause-specific survival was 87% (95% confidence interval: 86-89%) for women and 80% (78-82%) for men. Women had higher rates at any time since diagnosis. After adjustment for other confounders, women had a 34% reduced risk compared with men of dying from skin melanoma (hazard ratio=0.66, 95% confidence interval: 0.56-0.79). The present study confirmed a strong protective effect of female sex on skin melanoma mortality. The protective factor is still unknown.

Entities:  

Mesh:

Year:  2016        PMID: 26266895     DOI: 10.1097/CEJ.0000000000000190

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  10 in total

1.  Cancer survival in adult patients in Spain. Results from nine population-based cancer registries.

Authors:  M D Chirlaque; D Salmerón; J Galceran; A Ameijide; A Mateos; A Torrella; R Jiménez; N Larrañaga; R Marcos-Gragera; E Ardanaz; M Sant; P Minicozzi; C Navarro; M J Sánchez
Journal:  Clin Transl Oncol       Date:  2017-07-17       Impact factor: 3.405

2.  Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort.

Authors:  Tina J Hieken; Amy E Glasgow; Elizabeth Ann L Enninga; Lisa A Kottschade; Roxana S Dronca; Svetomir N Markovic; Matthew S Block; Elizabeth B Habermann
Journal:  J Womens Health (Larchmt)       Date:  2020-02-27       Impact factor: 2.681

3.  Patterns of increased incidence and survival of cutaneous melanoma in Girona (Spain) 1994-2013: a population-based study.

Authors:  J Rubió-Casadevall; M Puig-Vives; M Puigdemont; L Vilardell; A Carbó-Bagué; R Marcos-Gragera; N Vilar-Coromina
Journal:  Clin Transl Oncol       Date:  2018-06-05       Impact factor: 3.405

4.  Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results-based study.

Authors:  Lianyuan Tao; Haibo Yu; Yadong Dong; Guanjing Tian; Zhiyuan Ren; Deyu Li
Journal:  Cancer Med       Date:  2019-08-13       Impact factor: 4.452

5.  Skin melanoma survival is not superior in females in the new stage IIID of the 8th edition of the staging system: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) database.

Authors:  Ran Mo; Chen Chen; Lin Mi; Zhouji Ma; Qian Tan
Journal:  Ann Transl Med       Date:  2020-11

6.  Sex-specific survival benefit in early skin melanoma based on 8th AJCC edition: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) database.

Authors:  Ran Mo; Chen Chen; Yanan Jiang; Zhouji Ma; Xueyong Meng; Qian Tan
Journal:  Ann Transl Med       Date:  2021-01

7.  Trends in short-term survival from distant-stage cutaneous melanoma in the United States, 2001-2013 (CONCORD-3).

Authors:  Veronica Di Carlo; Jacques Estève; Christopher Johnson; Fabio Girardi; Hannah K Weir; Reda J Wilson; Pamela Minicozzi; Rosemary D Cress; Charles F Lynch; Karen S Pawlish; Judith R Rees; Michel P Coleman; Claudia Allemani
Journal:  JNCI Cancer Spectr       Date:  2020-09-14

Review 8.  Living with Metastatic Cancer: A Roadmap for Future Research.

Authors:  Danielle B Tometich; Kelly A Hyland; Hatem Soliman; Heather S L Jim; Laura Oswald
Journal:  Cancers (Basel)       Date:  2020-12-08       Impact factor: 6.639

9.  Risk of Cardiovascular Disease Death in Older Malignant Melanoma Patients: A Population-Based Study.

Authors:  Jiapeng Miao; Yujie Wang; Xiaoyu Gu; Wenrui Lin; Zhen Ouyang; Mi Wang; Mingliang Chen; Shuang Zhao; Xianggui Wang; Juan Su
Journal:  Cancers (Basel)       Date:  2022-09-30       Impact factor: 6.575

10.  Cutaneous melanoma: a retrospective study of 18 years. Are there gender differences?

Authors:  Bruno de Castro E Souza; Diego Henrique Morais Silva; Neusa Yuriko Sakai Valente; Priscila Kakizaki; Maria Claudia Alves Luce; Luiza Groba Bandeira
Journal:  An Bras Dermatol       Date:  2021-07-18       Impact factor: 1.896

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.